Singapore markets closed

Relay Therapeutics, Inc. (RLAY)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
6.64+0.13 (+2.00%)
At close: 04:00PM EDT
6.64 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-329,121
-341,973
-290,509
-363,872
-52,412
Depreciation & amortisation
5,467
5,269
4,130
3,925
3,549
Stock-based compensation
91,701
86,031
56,138
48,454
31,960
Change in working capital
-31,894
-32,458
11,246
97,344
-85,170
Accounts receivable
286
306
97
74,677
-75,000
Accounts payable
-3,692
-2,394
1,989
930
-410
Other working capital
-287,500
-304,442
-238,552
-77,877
-104,420
Other non-cash items
-7,251
-6,422
-11,677
137,691
-
Net cash provided by operating activities
-283,509
-300,316
-229,490
-74,406
-102,489
Cash flows from investing activities
Investments in property, plant and equipment
-3,991
-4,126
-9,062
-3,471
-1,931
Acquisitions, net
-
0
0
-25,298
0
Purchases of investments
-478,511
-385,542
-535,419
-980,665
-266,455
Sales/maturities of investments
675,353
647,302
355,736
529,923
350,058
Net cash used for investing activities
192,851
257,634
-188,745
-479,511
81,672
Cash flows from financing activities
Common stock issued
78,016
30,281
284,744
382,210
425,293
Other financing activities
-
-
-
-
-2,507
Net cash used provided by (used for) financing activities
82,378
34,753
289,910
388,090
426,509
Net change in cash
-8,280
-7,929
-128,325
-165,827
405,692
Cash at beginning of period
163,853
154,372
282,697
448,524
42,832
Cash at end of period
155,573
146,443
154,372
282,697
448,524
Free cash flow
Operating cash flow
-283,509
-300,316
-229,490
-74,406
-102,489
Capital expenditure
-3,991
-4,126
-9,062
-3,471
-1,931
Free cash flow
-287,500
-304,442
-238,552
-77,877
-104,420